Sickle cell crisis: Difference between revisions
No edit summary |
|||
| Line 16: | Line 16: | ||
==Clinical Features== | ==Clinical Features== | ||
=== Vaso-Occlusive Crisis<ref>Lovett P. et al. Sickle cell disease in the emergency department. Emerg Med Clin North Am. 2014 Aug;32(3):629-47</ref> === | ===Vaso-Occlusive Crisis<ref>Lovett P. et al. Sickle cell disease in the emergency department. Emerg Med Clin North Am. 2014 Aug;32(3):629-47</ref>=== | ||
*Pain | *Pain | ||
**Most common manifestation of SCA (79-91% of ED visits) | **Most common manifestation of SCA (79-91% of ED visits) | ||
| Line 33: | Line 33: | ||
**Pts p/w afebrile, inguinal pain with weight-bearing | **Pts p/w afebrile, inguinal pain with weight-bearing | ||
=== Respiratory Distress and Chest Pain === | ===Respiratory Distress and Chest Pain=== | ||
*[[Acute Chest Syndrome]] | *[[Acute Chest Syndrome]] | ||
*PNA | *PNA | ||
| Line 45: | Line 45: | ||
***Chest pain, DOE, hypoxia, right-sided heart failure, syncope, PE | ***Chest pain, DOE, hypoxia, right-sided heart failure, syncope, PE | ||
=== Abdominal Pain === | ===Abdominal Pain=== | ||
*Pain crisis | *Pain crisis | ||
**3rd most common site of pain crisis | **3rd most common site of pain crisis | ||
| Line 60: | Line 60: | ||
**Consider treatment with ciprofloxacin and bactrim in ill-appearing | **Consider treatment with ciprofloxacin and bactrim in ill-appearing | ||
=== Infection === | ===Infection=== | ||
*Across all ages, infection is leading cause of death | *Across all ages, infection is leading cause of death | ||
**Increased prevalence of meningitis, PNA, arthritis, osteo | **Increased prevalence of meningitis, PNA, arthritis, osteo | ||
| Line 75: | Line 75: | ||
****Can cause serious anemia which lasts for 2wk | ****Can cause serious anemia which lasts for 2wk | ||
=== Musculoskeletal Infection === | ===Musculoskeletal Infection=== | ||
*Pts w/ SCD have increased rates of bone and joint infection | *Pts w/ SCD have increased rates of bone and joint infection | ||
**Difficult to distinguish from bony infarcts | **Difficult to distinguish from bony infarcts | ||
| Line 84: | Line 84: | ||
***May require bone scan or MRI to definitely distinguish infection from infarct | ***May require bone scan or MRI to definitely distinguish infection from infarct | ||
=== Splenic Sequestration === | ===Splenic Sequestration=== | ||
*Major cause of mortality in <5yr old | *Major cause of mortality in <5yr old | ||
*Labs: Hb drop, no change in bili, normal to incr retic count | *Labs: Hb drop, no change in bili, normal to incr retic count | ||
| Line 95: | Line 95: | ||
****More insidious, smaller drop in Hb | ****More insidious, smaller drop in Hb | ||
=== Neurologic Disease === | ===Neurologic Disease=== | ||
*CVA is 250x more common in children with SCD | *CVA is 250x more common in children with SCD | ||
**10% of children suffer clinically overt stroke | **10% of children suffer clinically overt stroke | ||
| Line 101: | Line 101: | ||
*Increased rate of cerebral aneurysm and ICH | *Increased rate of cerebral aneurysm and ICH | ||
=== GU === | ===GU=== | ||
*Priapism | *Priapism | ||
**Occurs in 25% by age 20 | **Occurs in 25% by age 20 | ||
| Line 110: | Line 110: | ||
{{Sickle cell DDX}} | {{Sickle cell DDX}} | ||
== Diagnosis== | ==Diagnosis== | ||
*CBC | ===Work-up=== | ||
''Based on clinical presentation, but may include:'' | |||
* | *CBC (assess for significant anemia) | ||
*Reticulocyte count (<0.5% suggests aplastic crisis - rare in adults) | |||
*Metabolic panel, lipase (if c/o abd pain) | |||
* | *CXR (if c/o cough, SOB, or fever) | ||
*CXR | |||
*ECG | *ECG | ||
*VBG | *VBG | ||
*UA | *UA | ||
* | *Pregnancy test | ||
* | *CT Brain (if sx of CVA) | ||
** | |||
===Evaluation=== | |||
*Generally a clinical diagnosis | |||
*Certain syndromes require imaging/labs for confirmation (see below) | |||
== | ==Management== | ||
=== Anemia === | ===Anemia=== | ||
*Transfusion | *Transfusion | ||
**Indications: | **Indications: | ||
| Line 140: | Line 137: | ||
**Transfuse 10 mL/kg over 2hr period | **Transfuse 10 mL/kg over 2hr period | ||
=== Vaso-Occlusive Pain Crisis === | ===Vaso-Occlusive Pain Crisis=== | ||
*Analgesia | *Analgesia | ||
**IV opiods prefered (Morphine or hydormorphone) | **IV opiods prefered (Morphine or hydormorphone) | ||
| Line 154: | Line 151: | ||
**1.5 times maintenance w/ D5 1/2NS | **1.5 times maintenance w/ D5 1/2NS | ||
**Normal Saline boluses for hypovolemic shock | **Normal Saline boluses for hypovolemic shock | ||
*O2 is not useful in the | *O2 is not useful in the normoxic patient | ||
=== Acute Chest Syndrome === | ===Acute Chest Syndrome=== | ||
*See [[Acute Chest Syndrome]] | *See [[Acute Chest Syndrome]] | ||
=== Priapism === | ===Priapism=== | ||
*Hydration | *Hydration | ||
*Transfsuion and/or exchange transfusion | *Transfsuion and/or exchange transfusion | ||
| Line 167: | Line 164: | ||
**Irrigate and infuse 1:1,000,000 epi solution | **Irrigate and infuse 1:1,000,000 epi solution | ||
=== Neurologic Disease === | ===Neurologic Disease=== | ||
*t-PA is not recommended | *t-PA is not recommended | ||
*Exchange transfusion urgently (within 8 hours) to decrease HbS below 30% | *Exchange transfusion urgently (within 8 hours) to decrease HbS below 30% | ||
| Line 176: | Line 173: | ||
*Simple transfusion vs exchange transfusion | *Simple transfusion vs exchange transfusion | ||
== Disposition == | ==Disposition== | ||
*Consider admission to the hospital if: | *Consider admission to the hospital if: | ||
**Acute chest syndrome is suspected | **Acute chest syndrome is suspected | ||
| Line 191: | Line 188: | ||
**Ensure resource for follow-up | **Ensure resource for follow-up | ||
== See Also == | ==See Also== | ||
*[[Acute Chest Syndrome]] | *[[Acute Chest Syndrome]] | ||
*[[Aplastic crisis]] | *[[Aplastic crisis]] | ||
Revision as of 03:27, 12 March 2016
Background
Precipitating Factors
- For vaso-occlusion:
- Stress
- Cold weather
- Dehydration
- Hypoxia
- Infection
- Acidosis
- Alcohol intoxication
- Pregnancy
- Exertional stress
- For aplastic crisis:
- Parvovirus B19 infection
- Folic acid deficiency
Clinical Features
Vaso-Occlusive Crisis[1]
- Pain
- Most common manifestation of SCA (79-91% of ED visits)
- Lower back, long bones most commonly affected
- Because anemia can precipitate a crisis, must check for acute Hb drop
- Bony infarction
- More debilitating and refractory pain than past episodes
- Localized bone tenderness, elevated WBC
- Fat embolism can be complication
- Dactylitis
- Tender, swollen hands/feet
- May have low-grade fever
- Occurs in <2yr old, extremely rare >5yr old
- Avascular necrosis of femoral head
- Occurs in 30% of patients by age 30yr
- Pts p/w afebrile, inguinal pain with weight-bearing
Respiratory Distress and Chest Pain
- Acute Chest Syndrome
- PNA
- Caused by chlamydia, mycoplasma, viral, strep pneumo, staph, H. Flu
- Only need blood cx in pts ill enough to require ventilator
- Asthma
- Common in pts with SCD
- Increases likelihood of chest syndrome by 4-6x
- Pulmonary Hypertension
- Develops in 15-35% of children with SCD
- Chest pain, DOE, hypoxia, right-sided heart failure, syncope, PE
- Develops in 15-35% of children with SCD
Abdominal Pain
- Pain crisis
- 3rd most common site of pain crisis
- Sudden onset of poorly localized abdominal pain
- May have tenderness, guarding; should not have rigidity/rebound
- Gallbladder disease (stones) is common; may occur as early as 2-4yr old
- RUQ pain, jaundice, anorexia, tender hepatomegaly, fever
- Bilirubin level higher than usual (>4mg/dL)
- Acute hepatic sequestration
- Labs are variable
- US or CT shows diffuse hepatomegaly
- Bacterial gastroenteritis
- Increased risk for salmonella
- Consider treatment with ciprofloxacin and bactrim in ill-appearing
Infection
- Across all ages, infection is leading cause of death
- Increased prevalence of meningitis, PNA, arthritis, osteo
- Children aged 6mo to 3yr at greatest risk for sepsis
- Parvovirus B19
- Can cause several different syndromes:
- 1. Erythema infectiosum ("slapped cheeks" rash)
- 2. Gloves and socks syndrome
- Well-demarcated, painful, erythema of hands and feet
- Evolves nto petechiae, purpura, vesicles, skin sloughing
- Well-demarcated, painful, erythema of hands and feet
- 3. Arthropathy - symmetric or asymmetric, knees and ankles
- 4. Aplastic crisis
- Reticulocyte count drops 5d post-exposure, followed by Hb drop
- Can cause serious anemia which lasts for 2wk
- Can cause several different syndromes:
Musculoskeletal Infection
- Pts w/ SCD have increased rates of bone and joint infection
- Difficult to distinguish from bony infarcts
- High fever is more typical of infection
- Limited range of motion is much more typical of infection
- Left shift is unique to infection
- ESR is unreliable
- May require bone scan or MRI to definitely distinguish infection from infarct
- Difficult to distinguish from bony infarcts
Splenic Sequestration
- Major cause of mortality in <5yr old
- Labs: Hb drop, no change in bili, normal to incr retic count
- 2 types: major and minor
- Major
- Rapid drop of hb (>3pt)
- Pallor, LUQ pain, splenomegaly
- Can progress w/in hours to AMS, hypotension, CV collapse
- Minor
- More insidious, smaller drop in Hb
- Major
- 2 types: major and minor
Neurologic Disease
- CVA is 250x more common in children with SCD
- 10% of children suffer clinically overt stroke
- 20% found to have silent CVA on imaging
- Increased rate of cerebral aneurysm and ICH
GU
- Priapism
- Occurs in 25% by age 20
- Papillary necrosis
- Hematuria w/o casts or pyuria
Differential Diagnosis
Sickle cell crisis
- Vaso-occlusive pain crisis
- Bony infarction
- Dactylitis
- Avascular necrosis of femoral head
- Acute chest syndrome
- Asthma
- Pulmonary hypertension
- Gallbladder disease
- Acute hepatic sequestration
- Infection
- Parvovirus B19
- Splenic sequestration
- CVA
- Cerebral aneurysm and ICH
- Priapism
- Papillary necrosis
Diagnosis
Work-up
Based on clinical presentation, but may include:
- CBC (assess for significant anemia)
- Reticulocyte count (<0.5% suggests aplastic crisis - rare in adults)
- Metabolic panel, lipase (if c/o abd pain)
- CXR (if c/o cough, SOB, or fever)
- ECG
- VBG
- UA
- Pregnancy test
- CT Brain (if sx of CVA)
Evaluation
- Generally a clinical diagnosis
- Certain syndromes require imaging/labs for confirmation (see below)
Management
Anemia
- Transfusion
- Indications:
- Aplastic crisis
- Sequestration crisis
- Hb <6 w/ inappropriately low retic count
- Hb <10 w/ acute crisis
- Transfuse 10 mL/kg over 2hr period
- Indications:
Vaso-Occlusive Pain Crisis
- Analgesia
- IV opiods prefered (Morphine or hydormorphone)
- Avoid IM route (use SQ if necessary)
- Avoid meperidine
- Use PCA pump if available
- Redose in 30min if inadequate
- Normally admit if needs more than three doses
- Use of concurrent acetaminophen encouraged, unless contraindicated
- Consider Diphenhydramine (25 or 50mg PO)
- IV opiods prefered (Morphine or hydormorphone)
- Hydration
- O2 is not useful in the normoxic patient
Acute Chest Syndrome
Priapism
- Hydration
- Transfsuion and/or exchange transfusion
- Urology consult
- If persists for >4-6hr:
- Aspiration of corpora
- Irrigate and infuse 1:1,000,000 epi solution
Neurologic Disease
- t-PA is not recommended
- Exchange transfusion urgently (within 8 hours) to decrease HbS below 30%
- Hydration
Splenic Sequestration
- Volume resuscitation
- Simple transfusion vs exchange transfusion
Disposition
- Consider admission to the hospital if:
- Acute chest syndrome is suspected
- Sepsis, osteomyelitis, or other serious infection is suspected
- Priapism, aplastic crisis, hypoxia
- WBC >30K
- Plt <100K
- Pain is not under control after 2-3 rounds of analgesics in ED
- <1yr old
- Consider discharge if:
- Pain is under control and patient can take oral fluids and medications
- Ensure appropriate oral analgesics are available
- Provide home care instructions
- Ensure resource for follow-up
See Also
References
- ↑ Lovett P. et al. Sickle cell disease in the emergency department. Emerg Med Clin North Am. 2014 Aug;32(3):629-47
- ↑ Guy, R. Treatment of Sickle Cell Crisis with Hypotonic Saline Clinical Research 1971; 19: 420
- ↑ Pathogenesis and Treatment of Sickle Cell Disease H. Franklin Bunn, M.D. N Engl J Med 1997; 337:762-769
